A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: Features and prognosis after adrenalectomy

BMC Urology

Volumn 14, Issue 1, 2014, Pages

  Yang, Bo ^a   Yang, Yuan ^a   Tu, Wenling ^a   Shen, Ying ^a   Dong, Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adrenalectomy; CACNA1S; Hypokalaemic periodic paralysis; Unilateral adrenal hyperplasia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALDOSTERONE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CREATINE KINASE; CREATININE; EPINEPHRINE; HYDROCORTISONE; LACTATE DEHYDROGENASE; LIOTHYRONINE; NORADRENALIN; POTASSIUM; POTASSIUM CHLORIDE; RENIN; THYROTROPIN; THYROXINE; CACNA1S PROTEIN, HUMAN; CALCIUM CHANNEL;

ABDOMINAL RADIOGRAPHY; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADRENALIN BLOOD LEVEL; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CACNA1S GENE; CALCIUM BLOOD LEVEL; CASE REPORT; COLOR DOPPLER FLOWMETRY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; ELECTROCARDIOGRAM; EXON; FAMILY HISTORY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HEART PALPITATION; HETEROZYGOTE DETECTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOKALEMIC PERIODIC PARALYSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; MALE; MINERAL SUPPLEMENTATION; MISSENSE MUTATION; MUSCLE WEAKNESS; NORADRENALIN BLOOD LEVEL; OUTPATIENT; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; POTASSIUM DEFICIENCY; PROGNOSTIC ASSESSMENT; SCN4A GENE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; ADRENAL GLAND; COMPLICATION; GENETICS; HYPERPLASIA; PATHOLOGY; PROGNOSIS; SURGERY;

ADRENAL GLANDS; ADRENALECTOMY; ADULT; CALCIUM CHANNELS; HUMANS; HYPERPLASIA; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MUTATION, MISSENSE; PROGNOSIS;

EID: 84964313350     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-14-96     Document Type: Article

References (16)

1. Jiang SB, Guo XD, Wang HB, Gong RZ, Xiong H, Wang Z, Zhang HY, Jin XB: A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia. Int Urol Nephrol 2014, 46:1283-1288.
2. Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G: Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord 2012, 12:17.
3. Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Tropea S, Mantero F, Rossi GP, Fassina A, Nitti D, Favia G: Unilateral adrenal hyperplasia: A novel cause of surgically correctable primary hyperaldosteronism. Surgery 2012, 152:1248-1255.
4. Huang YY, Hsu BR, Tsai JS: Paralytic myopathy-A leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab 1996, 81:4038-4041.
5. Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, Links TP, Piussan C, Vila A, Monnier N, Padberg GW, Abe K, Feingold N, Guimaraes J, Wintzen AR, van der Hoeven JH, Saudubray JM, Grunfeld JP, Lenoir G, Nivet H, Echenne B, Frants RR, Fardeau M, Lehmann-Horn F, Fontaine B: Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet 1995, 56:374-380.
6. Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D, Tabti N, Lehmann-Horn F, Hainque B, Fontaine B: Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 2001, 124:1091-1099.
7. Fontaine B, Vale-Santos J, Jurkat-Rott K, Reboul J, Plassart E, Rime CS, Elbaz A, Heine R, Guimarães J, Weissenbach J, Baumann N, Fardeau M, Lehmann-Horn F: Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet 1994, 6:267-272.
8. Bulman DE, Scoggan KA, van Oene MD, Nicolle MW, Hahn AF, Tollar LL, Ebers GC: A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 1999, 53:1932-1936.
9. Weiner ID, Wingo CS: Hypokalemia-consequences, causes, and correction. J Am Soc Nephrol 1997, 8:1179-1188.
10. Kayal AK, Goswami M, Das M, Jain R: Clinical and biochemical spectrum of hypokalemic paralysis in North: East India. Ann Indian Acad Neurol 2013, 16:211-217.
11. Morrill JA, Cannon SC: Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-Type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol 1999, 520:321-336.
12. Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, Lerche H, Nicole S, Vale-Santos J, Chauveau D, Fontaine B, Lehmann-Horn F: Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A 2000, 97:9549-9554.
13. Wang Q, Liu M, Xu C, Tang Z, Liao Y, Du R, Li W, Wu X, Wang X, Liu P, Zhang X, Zhu J, Ren X, Ke T, Wang Q, Yang J: Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med (Berl) 2005, 83:203-208.
14. Kotsaftis P, Savopoulos C, Agapakis D, Ntaios G, Tzioufa V, Papadopoulos V, Fahantidis E, Hatzitolios A: Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism-An elderly patient with unilateral adrenal hyperplasia: A case report. Cases J 2009, 2:6813.
15. Amar L, Plouin PF, Steichen O: Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis 2010, 5:9.
16. Ng HY, Lin SH, Hsu CY, Tsai YZ, Chen HC, Lee CT: Hypokalemic paralysis due to Gitelman syndrome: A family study. Neurology 2006, 67:1080-1082.